GO:0004322 ferroxidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004322 ferroxidase activity catalyzes the oxidation of four ferrous ions (Fe2+) to four ferric ions (Fe3+) using oxygen and protons, as defined by QuickGO.
• This activity is essential for iron homeostasis, preventing toxic Fe2+ accumulation and enabling safe Fe3+ transport and storage.
• Key enzymes include ceruloplasmin (CP), hephaestin (HEPH), hephaestin-like 1 (HEPHL1), and ferritin, each with distinct tissue distributions and physiological roles.
• Defects in ferroxidase activity cause iron overload disorders such as aceruloplasminemia, characterized by neurodegeneration and diabetes.
• Ferroxidase activity is required for the stability of ferroportin on the cell surface, linking iron export to oxidation.
• Research methods include spectrophotometric assays, CRISPR knockout models, and nanoparticle-based systems to study ferroxidase function.
Description
Ferroxidase activity (GO:0004322) is a fundamental molecular function that enables the safe oxidation of ferrous iron (Fe2+) to ferric iron (Fe3+), a critical step in iron metabolism. This reaction prevents the accumulation of toxic Fe2+ and facilitates the incorporation of iron into transferrin and ferritin, thereby maintaining systemic iron homeostasis. The QuickGO definition describes the catalysis of 4 Fe2+ + 4 H+ + O2 = 4 Fe3+ + 2 H2O, highlighting the role of oxygen as an electron acceptor. Researchers study ferroxidase activity to understand iron-related pathologies, including neurodegenerative diseases and anemia, and to develop therapeutic interventions targeting iron overload. The enzymes exhibiting this activity, such as ceruloplasmin and hephaestin, are multicopper oxidases that couple iron oxidation to copper-dependent electron transfer. This article provides a comprehensive overview of the mechanism, genes, diseases, and research methodologies associated with GO:0004322, based on authoritative QuickGO data and verified PubMed literature.
ferroxidase activity At A Glance
| GO ID | GO:0004322 |
|---|---|
| GO term | ferroxidase activity |
| Ontology | molecular_function |
| Synonym | ceruloplasmin, ferroxidase I, hephaestin, Fe(II):oxygen oxidoreductase activity |
| Major function | Oxidation of Fe2+ to Fe3+ for iron homeostasis |
| Reaction | 4 Fe2+ + 4 H+ + O2 = 4 Fe3+ + 2 H2O |
| Cofactors | Copper (multicopper oxidases) |
| Localization | Secreted, membrane-bound, or intracellular |
| Disease relevance | Aceruloplasminemia, iron overload, neurodegeneration |
What Is GO:0004322?
Ferroxidase activity (GO:0004322) is defined by QuickGO as the catalysis of the reaction: 4 Fe2+ + 4 H+ + O2 = 4 Fe3+ + 2 H2O. In other words, it is the enzyme-mediated oxidation of ferrous iron to ferric iron, coupled with the reduction of oxygen to water. This activity is essential for iron detoxification and transport, as Fe3+ is the form that can be safely bound by transferrin and stored in ferritin.
Why Is ferroxidase activity Important in Cell Biology?
Ferroxidase activity is crucial for maintaining iron homeostasis and preventing oxidative stress caused by excess ferrous iron. By converting Fe2+ to Fe3+, it enables safe iron transport and storage, and its dysfunction leads to severe disorders such as aceruloplasminemia, a neurodegenerative disease with iron accumulation in the brain and viscera. Understanding this activity is therefore vital for developing treatments for iron-related diseases and for elucidating fundamental mechanisms of metal metabolism.
• Prevents toxic accumulation of Fe2+, which can catalyze free radical formation.
• Enables iron loading onto transferrin for systemic distribution.
• Required for the stability of ferroportin, the sole iron exporter.
• Mutations in HEPHL1 impair ferroxidase activity and cause abnormal hair phenotype.
• Ceruloplasmin ferroxidase activity is a biomarker for copper status and inflammation.
• Aceruloplasminemia results from loss of ceruloplasmin ferroxidase activity.
• Ferritin exhibits ferroxidase activity, important for iron storage.
• Nanoparticles can mimic or enhance ferroxidase activity for antibacterial applications.
• Ferroxidase activity is implicated in neurodegenerative diseases with iron dysregulation.
• Assays for ferroxidase activity are used in clinical diagnostics and drug discovery.
Molecular Mechanism of ferroxidase activity
Substrate Binding and Iron Oxidation
In simple terms: The enzyme grabs ferrous iron and turns it into ferric iron using oxygen.
Ferroxidase enzymes bind Fe2+ ions at catalytic sites, often coordinated by amino acid residues and copper ions. The oxidation of Fe2+ to Fe3+ involves electron transfer to molecular oxygen, forming water. This reaction is essential for iron detoxification and subsequent transport.
Role of Copper Cofactors
In simple terms: Copper atoms in the enzyme help move electrons during the reaction.
Multicopper oxidases such as ceruloplasmin and hephaestin contain multiple copper centers that facilitate electron transfer from Fe2+ to O2. The copper ions cycle between oxidized and reduced states, enabling efficient catalysis.
Coupling to Iron Transport
In simple terms: The oxidation of iron is linked to its export from cells.
Ferroxidase activity is functionally coupled to ferroportin-mediated iron export. Oxidation of Fe2+ to Fe3+ is required for ferroportin stability and for loading Fe3+ onto transferrin, preventing re-uptake of Fe2+.
Regulation by Substrate Availability
In simple terms: The enzyme works faster when there is more iron or oxygen around.
Ferroxidase activity is influenced by the availability of Fe2+ and oxygen, as well as by pH. Under physiological conditions, the reaction proceeds efficiently, but imbalances can lead to pathology.
Inhibition and Oxidative Stress
In simple terms: Too much iron or other factors can slow down the enzyme and cause damage.
Excess Fe2+ or reactive oxygen species can impair ferroxidase activity, contributing to oxidative stress. This is relevant in diseases like aceruloplasminemia where unregulated Fe2+ leads to lipid peroxidation and cell death.
Key Genes Involved in GO:0004322 ferroxidase activity
The following genes encode proteins with ferroxidase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CP | Ceruloplasmin, major plasma ferroxidase | Aceruloplasminemia, iron homeostasis |
| HEPH | Hephaestin, intestinal ferroxidase | Iron absorption, anemia |
| HEPHL1 | Hephaestin-like 1, ferroxidase | Hair phenotype, iron metabolism |
| FTL | Ferritin light chain, ferroxidase | Iron storage, neurodegeneration |
| FTH1 | Ferritin heavy chain, ferroxidase | Iron storage, antioxidant |
| SLC40A1 | Ferroportin, iron exporter | Ferroportin disease, iron overload |
| CP | Ceruloplasmin, copper-dependent | Copper metabolism, Wilson disease |
| HEPH | Hephaestin, membrane-bound | Iron export from enterocytes |
| HEPHL1 | Hephaestin-like 1, GPI-anchored | Hair development |
| FTL | Ferritin light chain, iron storage | Neuroferritinopathy |
| FTH1 | Ferritin heavy chain, ferroxidase | Iron overload, cancer |
| CP | Ceruloplasmin, acute phase protein | Inflammation, copper status |
| HEPH | Hephaestin, multicopper oxidase | Iron deficiency anemia |
| HEPHL1 | Hephaestin-like 1, ferroxidase | Uncombable hair syndrome |
| SLC40A1 | Ferroportin, iron export | Hemochromatosis |
| CP | Ceruloplasmin, ferroxidase I | Diabetes, neurodegeneration |
| FTH1 | Ferritin heavy chain, ferroxidase | Iron chelation therapy |
How Is ferroxidase activity Regulated?
Ferroxidase activity is regulated at multiple levels, including transcriptional control of genes like CP and HEPH by iron status and inflammation. Copper availability affects the maturation and activity of multicopper ferroxidases, as copper is a cofactor. Additionally, ferroportin stability, which depends on ferroxidase activity, is regulated by hepcidin, a hormone that binds to ferroportin and induces its degradation. Post-translational modifications and interactions with other proteins also modulate ferroxidase function.
ferroxidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CP | Aceruloplasminemia | CP knockout mice, patient iPSCs |
| HEPHL1 | Uncombable hair syndrome | HEPHL1 knockout mice, hair follicle organoids |
| FTL | Neuroferritinopathy | FTL knock-in mice, neuronal cultures |
| SLC40A1 | Ferroportin disease | SLC40A1 knockout zebrafish, cell lines |
| FTH1 | Iron overload, cancer | FTH1 overexpression cell models |
Aceruloplasminemia
Aceruloplasminemia is an autosomal recessive disorder caused by mutations in the CP gene, leading to absent or dysfunctional ceruloplasmin ferroxidase activity. This results in iron accumulation in the brain, liver, and pancreas, causing neurodegeneration, diabetes, and retinopathy. The lack of ferroxidase activity impairs iron export from cells, leading to oxidative damage.
Hephaestin-like 1 Deficiency
Biallelic variants in HEPHL1 impair ferroxidase activity and cause an abnormal hair phenotype, including uncombable hair syndrome. This highlights the role of ferroxidase activity in hair development and iron metabolism in specific tissues.
Neurodegeneration with Brain Iron Accumulation
Disorders such as neuroferritinopathy, caused by mutations in FTL, involve impaired ferritin ferroxidase activity and iron accumulation in the brain. This leads to progressive neurodegeneration and movement disorders.
Iron Overload and Anemia
Dysregulation of ferroxidase activity can contribute to iron overload or anemia. For example, hephaestin deficiency impairs intestinal iron absorption, leading to anemia, while excess iron can exacerbate oxidative stress in various tissues.
From ferroxidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CP cause iron accumulation? | CP knockout mouse |
| How does HEPHL1 mutation affect hair? | HEPHL1 point-mutation knock-in mouse |
| Can ferroxidase activity be restored? | CP knock-in with human variant |
| Where is ferroxidase active in cells? | Tagged CP knock-in (e.g., GFP) |
| Does overexpression of FTH1 protect from oxidative stress? | FTH1 overexpression cell line |
| What genes regulate ferroxidase activity? | CRISPR library screening in iron-sensitive cells |
How to Study the ferroxidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometry | Fe2+ oxidation rate | Clinical diagnosis of aceruloplasminemia |
| CRISPR knockout | Gene function loss | Studying CP and HEPH roles |
| Nanoparticle catalysis | Ferroxidase-like activity | Antibacterial applications |
| Apoferritin assay | Ferroxidase enhancement | Nanoparticle effects |
| Western blot | Protein stability | Ferroportin stability |
| Iron staining | Tissue iron accumulation | Aceruloplasminemia models |
| qPCR | Gene expression | Regulation by iron |
Spectrophotometric Assays
Ferroxidase activity is commonly measured using spectrophotometric methods that monitor the oxidation of Fe2+ to Fe3+, often coupled to a chromogenic substrate. A new method for measuring ceruloplasmin ferroxidase activity has been developed for clinical use.
CRISPR-Cas9 Knockout Models
CRISPR knockout of genes like CP, HEPH, and HEPHL1 in cell lines and animal models allows researchers to study the consequences of loss of ferroxidase activity on iron homeostasis and disease phenotypes.
Nanoparticle-Based Systems
Platinum-copper alloy nanoparticles exhibit ferroxidase-like activity and antibacterial properties, providing a model to study catalytic mechanisms and potential applications. Similarly, platinum nanoparticles enhance apoferritin ferroxidase activity.
Protein-Protein Interaction Studies
Co-immunoprecipitation and proximity ligation assays can reveal interactions between ferroxidases and partners like ferroportin, elucidating regulatory mechanisms.
How CRISPR Can Be Used to Study GO:0004322 ferroxidase activity
Knockout
CRISPR knockout of CP, HEPH, or HEPHL1 in cell lines and mice recapitulates loss of ferroxidase activity, leading to iron accumulation and oxidative stress. These models are essential for studying disease mechanisms and testing therapies.
Point Mutation
Introducing disease-associated point mutations (e.g., in HEPHL1) via CRISPR allows precise modeling of impaired ferroxidase activity and its phenotypic consequences, such as hair abnormalities.
Knock-in
Knock-in of tagged ferroxidase enzymes (e.g., GFP-CP) enables live-cell imaging and tracking of protein localization and dynamics, providing insights into trafficking and function.
Overexpression
Overexpression of ferroxidases like FTH1 or CP using CRISPR activation or lentiviral vectors can protect cells from iron-induced toxicity and is used to study gain-of-function effects.
How EDITGENE Supports ferroxidase activity Research
Researchers studying ferroxidase activity-related genes often need to determine whether a candidate gene is causally involved in iron metabolism, disease, or cellular stress responses. EDITGENE provides comprehensive CRISPR-based services to create precise cellular and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for ferroxidase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CP Knockout HEK293 Cell Line | EDJ-KQ3300 | Human | 1356 | Details Get a Quote |
| HEPH Knockout HEK293 Cell Line | EDJ-KQ6780 | Human | 9843 | Details Get a Quote |
| FTMT Knockout HEK293 Cell Line | EDJ-KQ11274 | Human | 94033 | Details Get a Quote |
| HEPHL1 Knockout HEK293 Cell Line | EDJ-KQ13738 | Human | 341208 | Details Get a Quote |
| CP Knockout A-549 Cell Line | EDJ-KQ24883 | Human | 1356 | Details Get a Quote |
| FXN Knockout HEK293 Cell Line | EDJ-KQ50282 | Human | 2395 | Details Get a Quote |
| FTH1 Knockout HEK293 Cell Line | EDJ-KQ50284 | Human | 2495 | Details Get a Quote |
| CP Knockout HeLa Cell Line | EDJ-KQ52965 | Human | 1356 | Details Get a Quote |
| FXN Knockout HeLa Cell Line | EDJ-KQ53266 | Human | 2395 | Details Get a Quote |
| FTH1 Knockout HeLa Cell Line | EDJ-KQ53271 | Human | 2495 | Details Get a Quote |
| HEPH Knockout HeLa Cell Line | EDJ-KQ55265 | Human | 9843 | Details Get a Quote |
| FTMT Knockout HeLa Cell Line | EDJ-KQ57879 | Human | 94033 | Details Get a Quote |
| HEPHL1 Knockout HeLa Cell Line | EDJ-KQ59703 | Human | 341208 | Details Get a Quote |
| FXN Knockout A-549 Cell Line | EDJ-KQ61749 | Human | 2395 | Details Get a Quote |
| FTH1 Knockout A-549 Cell Line | EDJ-KQ61753 | Human | 2495 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About ferroxidase activity
What is ferroxidase activity?
Ferroxidase activity (GO:0004322) is the enzyme-catalyzed oxidation of ferrous iron (Fe2+) to ferric iron (Fe3+) using oxygen, as defined by QuickGO.
What genes are involved in ferroxidase activity?
Key genes include CP (ceruloplasmin), HEPH (hephaestin), HEPHL1 (hephaestin-like 1), FTL and FTH1 (ferritin subunits), and SLC40A1 (ferroportin).
What diseases are associated with ferroxidase activity?
Defects cause aceruloplasminemia, neurodegeneration with brain iron accumulation, and abnormal hair phenotypes.
How is ferroxidase activity measured?
It is measured by spectrophotometric assays that monitor Fe2+ oxidation, often using ceruloplasmin as the enzyme source.
What is the role of ceruloplasmin in iron metabolism?
Ceruloplasmin is a major plasma ferroxidase that oxidizes Fe2+ to Fe3+ for transferrin loading and iron export.
Can ferroxidase activity be targeted for therapy?
Yes, modulating ferroxidase activity is a potential strategy for iron overload disorders and neurodegenerative diseases.
What is aceruloplasminemia?
Aceruloplasminemia is a rare autosomal recessive disease caused by CP mutations, leading to iron accumulation in brain and viscera.
How does hephaestin differ from ceruloplasmin?
Hephaestin is a membrane-bound ferroxidase primarily in the intestine, while ceruloplasmin is secreted into plasma.
What are the substrates of ferroxidase?
The substrates are Fe2+, H+, and O2, yielding Fe3+ and H2O.
What model systems are used to study ferroxidase activity?
Common models include CRISPR knockout mice and cell lines, patient-derived iPSCs, and nanoparticle-based systems.
Conclusion
Ferroxidase activity (GO:0004322) is a critical molecular function that maintains iron homeostasis by oxidizing Fe2+ to Fe3+. Its dysregulation leads to severe diseases such as aceruloplasminemia and neurodegeneration. Ongoing research using CRISPR models and advanced assays continues to unravel its mechanisms and therapeutic potential. EDITGENE offers tailored CRISPR services to support these investigations, from knockout to overexpression and screening.
References
- 1. Zhang X et al.. 2019. Ferroxidase-like and antibacterial activity of PtCu alloy nanoparticles.. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 37(2):99-115 PMID: 31099294
- 2. Miyajima H. 2015. Aceruloplasminemia.. Neuropathology 35(1):83-90 PMID: 25168455
- 3. Sharma P et al.. 2019. Biallelic HEPHL1 variants impair ferroxidase activity and cause an abnormal hair phenotype.. PLoS Genet 15(5):e1008143 PMID: 31125343
- 4. Hadwan MH et al.. 2024. A new spectrophotometric method for measuring ceruloplasmin ferroxidase activity: an innovative approach.. Biometals 37(6):1699-1712 PMID: 39400640
- 5. Kono S. 2012. Aceruloplasminemia.. Curr Drug Targets 13(9):1190-9 PMID: 22515740
- 6. Kono S. 2013. Aceruloplasminemia: an update.. Int Rev Neurobiol 110:125-51 PMID: 24209437
- 7. Sennuga A et al.. 2012. Ferroxidase activity of apoferritin is increased in the presence of platinum nanoparticles.. Nanotechnology 23(3):035102 PMID: 22173232
- 8. De Domenico I et al.. 2007. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.. EMBO J 26(12):2823-31 PMID: 17541408
